These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients. Friedrich RE, Blake FA. Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782 [Abstract] [Full Text] [Related]
3. Chronic indurated gingival ulceration. Bisphosphonate-related osteonecrosis of the jaw (BRONJ). Mas A, Mascaró JM. Arch Dermatol; 2010 Nov; 146(11):1301-6. PubMed ID: 21079075 [No Abstract] [Full Text] [Related]
5. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, Delaroudis S. Am J Otolaryngol; 2007 Nov; 28(3):158-63. PubMed ID: 17499130 [Abstract] [Full Text] [Related]
6. Is your osteoporosis medication killing your jaw? Research links bisphosphonates to rare, but serious, jaw osteonecrosis; prevention seen as best "cure". Duke Med Health News; 2006 Dec; 12(12):3-4. PubMed ID: 17294534 [No Abstract] [Full Text] [Related]
7. Bisphosphonates, dental care and osteonecrosis of the jaws. Sitters MA, Caldwell CS. Tex Dent J; 2005 Sep; 122(9):968-72. PubMed ID: 16320504 [No Abstract] [Full Text] [Related]
11. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G. J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571 [Abstract] [Full Text] [Related]
12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [Abstract] [Full Text] [Related]
13. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P. J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082 [Abstract] [Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Cancer; 2005 Jul 01; 104(1):83-93. PubMed ID: 15929121 [Abstract] [Full Text] [Related]
17. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws. Biasotto M, Chiandussi S, Dore F, Rinaldi A, Rizzardi C, Cavalli F, Di Lenarda R. Acta Odontol Scand; 2006 Nov 01; 64(6):348-54. PubMed ID: 17123911 [Abstract] [Full Text] [Related]